10th Annual Hematology and Medical Oncology Board Review: Contemporary Practice – On Demand 2022 (Videos)

Comprehensive Oncology Review Program

Solid Tumor Oncology

• Gastrointestinal:
  • Colon Cancer: Focus on advancements in screening, diagnosis, and treatment, including targeted therapies and immunotherapy.
• Gynecologic:
  • Uterine/Cervix/Other GYN Cancers: In-depth review of prevention, diagnosis, staging, and treatment strategies.
  • Ovarian Cancer: Emphasizing recent breakthroughs in biomarker development and personalized treatment approaches.
  • Breast Cancer: Surgery, Radiation Therapy, Genetics, Adjuvant Therapy, Advanced Disease, and Hormonal Therapy.
• Thoracic:
  • Small Cell Lung Cancer: Latest findings on molecular profiling and targeted therapies.
  • Non Small Cell Lung Cancer: Comprehensive coverage of diagnostic techniques, staging, and multidisciplinary management.
• Head and Neck:
  • Head and Neck, Thyroid, Non-melanoma Skin Cancer: Emphasizing early detection, surgical approaches, and advanced therapies.
• Genitourinary:
  • Prostate Cancer: Focus on risk assessment, active surveillance, and personalized treatment recommendations.
  • Kidney Cancer: Comprehensive review of nephrectomy, targeted therapies, and immunotherapy.
  • Urothelial Cancer: In-depth analysis of molecular classification and current treatment options.
  • Testis Cancer: Latest advances in diagnosis, risk stratification, and fertility preservation.
• Soft Tissue and Skin:
  • Sarcoma: Exploring emerging therapies and challenges in diagnosing and managing these rare tumors.
• Central Nervous System Oncology:
  • CNS Tumors: Emphasis on novel surgical techniques and advancements in radiation therapy.
• Hepatobiliary and Neuroendocrine:
  • Hepatocellular Cancer and Cholangiocarcinoma: Comprehensive review of targeted therapies and surgical interventions.
  • Pancreatic and Neuroendocrine Cancer: Latest developments in surgery, chemotherapy, and targeted therapies.

Hematologic Oncology

• Malignant Hematology:
  • CAR T cells: In-depth discussion of the science, indications, and clinical applications of CAR T-cell therapy.
  • Low Grade NHL: Focus on indolent lymphomas and the latest advances in management.
  • CLL/SLL: Comprehensive review of diagnosis, staging, and targeted therapies for chronic lymphocytic leukemia and small lymphocytic lymphoma.
  • DLBCL/MCL/BL: In-depth analysis of aggressive lymphomas, including diagnostic criteria, staging, and treatment approaches.
  • HL/T Cell: Emphasis on the management of Hodgkin lymphoma and T-cell lymphomas.
  • Auto/Allo: Review of autologous and allogeneic stem cell transplantation for hematologic malignancies.
  • ALL: Comprehensive coverage of acute lymphoblastic leukemia, including latest advancements in immunotherapies and targeted therapies.
  • AML: In-depth analysis of acute myeloid leukemia, focusing on molecular classification, risk stratification, and treatment options.
  • MDS/MPN: Focus on the diagnosis and management of myelodysplastic syndromes and myeloproliferative neoplasms.
  • Myeloma/Amyloid: Comprehensive review of multiple myeloma and amyloid light-chain amyloidosis, including novel therapeutic strategies.
• Benign Hematology:
  • Approach to The Bleeding Patient: In-depth discussion of diagnostic workup and management of bleeding disorders.
  • New Direct Oral Anticoagulants in Practice: Review of the latest evidence and practical implications of using NOACs.
  • Thrombocytopenia, ITP and Beyond: Comprehensive analysis of thrombocytopenia, including immune thrombocytopenia and other causes.
  • Sickle Cell Disease, Thalassemia: Focus on the pathophysiology, diagnosis, and current treatment approaches for these inherited blood disorders.